EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K / AKT / GSK3β Pathway Activation

Sun Xuecheng, Chen Changjun iD, Ma Xiaojie, Li Shufeng, Zhang Lei iD, Xinlong Ma iD

Orthopaedic Surgery · 2025-12 · 17 (12) · 3456-3467

DOI: 10.1111/os.70191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orthopaedic Surgery, online erschienen am 18.11.2025. Verfasst von Sun Xuecheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School/College of Orthopedics, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Selenium, Osteoblasts, Dexamethasone, Femur Head Necrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Clinical Medical Science and Technology Innovation Program of Jinan Science and Technology Bureau, Wu Jieping Medical Foundation Clinical Research Special Grant Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glucocorticoid‐induced osteonecrosis of the femoral head (GC‐ONFH) represents a devastating complication of steroid therapy, primarily driven by osteoblast apoptosis and impaired osteogenesis. Although selenium (Se) is renowned for its potent bone‐protective properties, its therapeutic potential, and specific mechanisms in GC‐ONFH remain largely unexplored and thus require further investigation.

Methods

To assess the therapeutic effectiveness of oral selenium supplementation in GC‐ONFH, a rat model of GC‐ONFH was utilized. The rats were randomly allocated into three groups ( n = 6 per group): (1) Control group, (2) Methylprednisolone sodium succinate (MPS) group, and (3) Se group. The intervention was carried out for 4 weeks. In vitro experiments utilized primary rat osteoblasts and MC3T3‐E1 cells to elucidate the mechanisms through which selenium mitigates dexamethasone (DEX)‐induced alterations in cell proliferation, apoptosis, and osteogenic differentiation. The assessments were conducted using micro‐CT and histomorphometry, CCK‐8 assays and flow cytometry, as well as RT–qPCR, Western blotting, and immunofluorescence.

Results

Selenium supplementation effectively prevented trabecular collapse and significantly reduced the number of empty lacunae in rats with GC‐ONFH. Specifically, an optimal dose of 10 μmol Se successfully reversed the damage induced by DEX, including the restoration of cell proliferation, suppression of apoptosis, and rescue of osteogenic activity. Mechanistically, Se counteracts the DEX‐induced suppression of phosphorylated phosphatidylinositol 3‐kinase (p‐PI3K), phosphorylated protein kinase B (p‐AKT), and phosphorylated glycogen synthase kinase 3β (GSK3β) (p‐GSK3β), thereby activating the PI3K/AKT/GSK3β signaling pathway, which promotes cell proliferation, inhibits apoptosis, and enhances osteogenesis in osteoblasts.

Conclusion

Selenium can activate the PI3K/AKT/GSK3β pathway, reverse DEX‐induced hypoproliferation and apoptosis, restore osteogenic capacity, prevent trabecular collapse, and attenuate GC‐ONFH in rat models. Our findings demonstrate that selenium supplementation can be regarded as a clinically applicable strategy for impeding the progression of GC‐ONFH in at‐risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeleniumOsteoblastsDexamethasoneFemur Head NecrosisAnimalsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesGlucocorticoidsRatsGlycogen Synthase Kinase 3 betaRats, Sprague-DawleySignal TransductionMaleApoptosisDisease Models, AnimalOsteogenesisCell Proliferation

Stichwörter der Autor:innen

apoptosisglucocorticoid‐induced osteonecrosis of the femoral headosteoblastproliferationselenium

Substanzen

SeleniumDexamethasoneProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesGlucocorticoidsGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Clinical School/College of Orthopedics, Tianjin Medical University, Tianjin, China.
  • Department of Orthopaedic Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Orthopaedics Surgery, Shandong Provincial Qianfoshan Hospital, Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan, China.

ORCID-Profile: Chen Changjun, Zhang Lei, Xinlong Ma

Förderung

  • Natural Science Foundation of Shandong Province
  • Clinical Medical Science and Technology Innovation Program of Jinan Science and Technology Bureau
  • Wu Jieping Medical Foundation Clinical Research Special Grant Fund
  • Weifang Science and Technology Development Project (Soft Science)

Zitieren

APA

Xuecheng, S., Changjun, C., Xiaojie, M., Shufeng, L., Lei, Z., & Ma, X. (2025). Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K / AKT / GSK3β Pathway Activation. Orthopaedic Surgery, 17(12), 3456-3467. https://doi.org/10.1111/os.70191

Vancouver

Xuecheng S, Changjun C, Xiaojie M, Shufeng L, Lei Z, Ma X. Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K / AKT / GSK3β Pathway Activation. Orthopaedic Surgery. 2025;17(12):3456-3467. doi:10.1111/os.70191

BibTeX
@article{Xuecheng2025,
  author = {Xuecheng, Sun and Changjun, Chen and Xiaojie, Ma and Shufeng, Li and Lei, Zhang and Ma, Xinlong},
  title = {Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K / AKT / GSK3β Pathway Activation},
  journal = {Orthopaedic Surgery},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {3456--3467},
  doi = {10.1111/os.70191}
}
Kostenlos starten →